Global Addictions Therapeutics Market 2021-2025

Global Addictions Therapeutics Market 2021-2025

The publisher has been monitoring the addictions therapeutics market and it is poised to grow by $ 6.30 bn during 2021-2025 progressing at a CAGR of 6% during the forecast period. The report on addictions therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high consumption of alcohol, tobacco, and opioid products and initiatives to increase awareness about and combat addiction. In addition, high consumption of alcohol, tobacco, and opioid products is anticipated to boost the growth of the market as well.

The addictions therapeutics market analysis includes type segment and geographical landscapes.

The addictions therapeutics market is segmented as below:

By Type

• Alcohol addiction therapeutics
• Tobacco addiction therapeutics
• Drug addiction therapeutics

By Geographical Landscapes

• North America
• Europe
• APAC
• ROW

This study identifies the approval of new drugs and launch of digital therapeutics to treat addiction as one of the prime reasons driving the addictions therapeutics market growth during the next few years.

The report on addictions therapeutics market covers the following areas:

• Addictions therapeutics market sizing
• Addictions therapeutics market forecast
• Addictions therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading addictions therapeutics market vendors that include Alkermes Plc, Emergent BioSolutions Inc., GlaxoSmithKline Plc, Indivior Plc, Mallinckrodt Plc, Orexo AB, Otsuka Holdings Co. Ltd., Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Titan Pharmaceuticals Inc.. Also, the addictions therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.